Godavari Biorefineries Share Price Gains Over 11%; Secures European Patent for Oncology Pharmaceutical Composition

On August 11, 2026, Godavari Biorefineries Limited announced the grant of a patent by the European Patent Office. The official notification regarding this intellectual property development was communicated to the stock exchanges on August 11, 2026. 

Details of the Pharmaceutical Patent 

The patent, identified by reference number EP4404920 and granted on July 15, 2026, relates to a pharmaceutical composition and its specific preparation process.  

This invention incorporates novel anti-cancer compounds combined with a solubilising agent to enhance solubility and bioavailability. 

The company states that the composition is intended to improve the therapeutic potential of active compounds.  

Its application covers the treatment and management of various cancers, with a specific focus on breast and prostate cancers through oral administration methods. 

Impact on Oncology Portfolio 

The granting of this patent by the European Patent Office serves to strengthen the intellectual property portfolio of Godavari Biorefineries Limited in the oncology sector. The document details the methodology for creating the composition, which is designed for effective delivery of anti-cancer agents. 

The company, headquartered at 45/47, Somaiya Bhavan, Mahatma Gandhi Road, Fort, Mumbai 400 001, filed this disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. 

Read More: Inox Wind Share Price in Focus; Q1 FY27 Profit Falls 34.2%, EBITDA Margin Narrows! 

Godavari Biorefineries Share Price Performance 

As of August 11, 2026, at 11:16 AM, Godavari Biorefineries share price on NSE was trading at ₹267.35, up by 11.35% from the previous closing price. 

Conclusion 

Godavari Biorefineries Limited was granted a patent for a pharmaceutical composition by the European Patent Office on July 15, 2026. The invention concerns a process for preparing anti cancer compounds intended for oral medical administration. 

Track the stock market in Hindi. Visit Angel One News for the latest market trends, insights, and share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.